Sevenless Therapeutics focus on manufacturing of pharmaceuticals.
Sevenless Therapeutics has raised $1.3M in total funding. The most recent round was Debt Financing. The last funding was announced in August 2022.
Sevenless Therapeutics's investors include BioInnovation Institute.
Sevenless Therapeutics is headquartered in Canterbury, United Kingdom.
Sevenless Therapeutics focus on manufacturing of pharmaceuticals.
Sevenless Therapeutics is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sevenless Therapeutics — Funding & Investors." VCBacked, August 22, 2022, https://www.vcbacked.co/company/sevenless-therapeutics. Accessed November 15, 2026.
VCBacked. (2022). Sevenless Therapeutics — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/sevenless-therapeutics
{{cite web |title=Sevenless Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/sevenless-therapeutics |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Sevenless Therapeutics? Request a listing update